Zongbi Yi

70PUBLICATIONS
87CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsEvolution of developmental systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (70)

|Jul 30, 2026
Low-Dose Antiangiogenic Therapy With Different Chemotherapy Backbones Among Patients With Heavily Pretreated Metastatic Breast Cancer.

|Jul 21, 2026
Dalpiciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial.

|Jul 02, 2026
Single cell spatial transcriptomics track the evolutionary hierarchy and microenvironment remodeling during breast carcinoma invasion.

|Jun 23, 2026
Efficacy and safety profiles of CDK4/6 inhibitor in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC) from the high-altitude versus low-altitude regions: a multi-center retrospective study.

|Jun 08, 2026
Expert Consensus on the Clinical Application of Poly ADP Ribose Polymerase Inhibitors in Breast Cancer (2025 Edition).

|Jun 08, 2026
Constructing Tumor Cellular Cluster Models and Their Evolutionary Dynamics to Decode Tumor Evolution.

Pageof 12

Frequent Collaborators

10 joint publications

Binghe Xu

9 joint publications

Bo Lan

8 joint publications

Hongnan Mo

7 joint publications

Qiao Li